Peak Pharmaceuticals, Inc. filed its 10-K on Dec 19, 2022 for the period ending Sep 30, 2022. In this report its auditor, Friedman LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.2 USD | +4.76% |
|
+4.76% | +27.17% |
1st Jan change | Capi. | |
---|---|---|
+27.17% | 43.94M | |
+16.55% | 91.26B | |
+14.38% | 84.76B | |
+43.04% | 53.8B | |
-20.43% | 49.15B | |
+35.81% | 46.84B | |
+83.19% | 43.59B | |
-29.60% | 42.88B | |
-1.19% | 27.95B | |
-22.51% | 22.52B |
- Stock Market
- Equities
- RMHI Stock
- News Retrieve Medical Holdings Inc
- Peak Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt